Overview

Psilocybin for Prolonged Grief Disorder

Status:
NOT_YET_RECRUITING

Trial end date:
2026-10-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to explore the feasibility of conducting a clinical trial on the effects of psilocybin for individuals with prolonged grief disorder (PGD).

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

University of Virginia

Treatments:

Psilocybin